Oct 18, 2018   SOURCE: PR NewsWire

United States Influenza Vaccines Market 2010-2025

DUBLIN, Oct. 18, 2018 /PRNewswire/ --

The "United States Influenza Vaccines Market Report, Analysis and Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

This report presents an in-depth assessment of the United States influenza vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for United States influenza vaccines market. The report includes historic data from 2013 to 2017 and forecasts until 2025.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the united states influenza vaccines market. The report also explores detailed analysis of the number of children and adults vaccinated with influenza vaccines in the United States from 2013 to 2017 and forecasts to 2025. The report also details the latest information about the influenza vaccines production, supply, and allocation by major companies in the United States.

A comprehensive analysis has been done on pricing, distribution & demand and effectiveness of influenza vaccines in the United States. It also provides a deep and thorough evaluation of distribution channel & technique of influenza vaccination. It covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes an assessment of clinical trials, promising influenza vaccines in clinical development and rapid diagnostic testing for the management of influenza. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States influenza vaccines market.

The report concludes with the profiles of major players in the United States influenza vaccines market. The key market players are evaluated on various parameters such as company overview, influenza vaccines portfolios, sales value analysis and the recent development of influenza vaccine market. Other emerging players such as Novavax, Daiichi-Sankyo, Mitsubishi TanabePharma and Biondvax Pharmaceuticals Ltd, are making novel technology-based influenza vaccines which are likely to affect the market share during the forecast period.

The major companies dominating this market for its products, services and continuous product developments are Seqirus, Sanofi Pasteur, GlaxoSmithKline (GSK) and AstraZeneca.

Data Included

    --  United States Influenza Vaccines Market Size & Analysis (2013 - 2025)
    --  United States Number of Persons Vaccinated with Influenza Vaccines (2013
        - 2025)
    --  United States Number of Children Vaccinated with Influenza Vaccines
        (2013 - 2025)
    --  United States Number of Adults Vaccinated with Influenza Vaccines (2013
        - 2025)
    --  United States Influenza Vaccines Pricing Trends & Analysis
    --  United States Influenza Vaccines Production, Supply, and Allocation (By
        Companies)
    --  United States Influenza Vaccines Distribution & Demand (2010 - 2018)
    --  Effectiveness of Influenza Vaccines in United States (2004 - 2018)
    --  Rapid Diagnostic Testing for the Management of Influenza
    --  Distribution Channel & Technique of Influenza Vaccination in United
        States
    --  United States Influenza Vaccines Reimbursement Policies & Regulatory
        System
    --  Major Deals in United States Influenza Vaccines Market
    --  Promising Influenza Vaccines in Clinical Development
    --  Influenza Vaccines Clinical Trial Insights by Phase, Company & Country
    --  Market Definition for the Specified Topic Along with Identification of
        Key Driver and Inhibitors for the Market
    --  A Comprehensive List of Key Market Players Along with the Analysis of
        their Current Vaccines Portfolios, Sales Value Analysis and Recent
        Development

Key Questions Answered

    --  At what pace is the influenza vaccines market growing in United States?
        What will be the growth trend in future?
    --  How many people are being vaccinated with influenza vaccines during 2013
        - 2025?
    --  What are the key drivers and inhibitors in the current market? What will
        be the impact of drivers and inhibitors in the future?
    --  What are the various influenza vaccines available in the United States?
    --  How is the market predicted to develop in the future?
    --  Who are the key players in this market space?

Companies Mentioned 

    --  AstraZeneca
    --  Biondvax Pharmaceuticals Ltd
    --  Daiichi-Sankyo
    --  GlaxoSmithKline (GSK)
    --  Mitsubishi TanabePharma
    --  Novavax
    --  Sanofi Pasteur
    --  Seqirus

For more information about this report visit https://www.researchandmarkets.com/research/mljwbg/united_states?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/united-states-influenza-vaccines-market-2010-2025-300733876.html

SOURCE Research and Markets